Pharmacology & ToxicologyFrontiers in PharmacologyPeer-reviewed
Agonist efficacy at the B2AR is driven by agonist-induced differences in receptor affinity for the Gs protein, not ligand binding kinetics.
Clare R. Harwood, David A. Sykes, Theo Redfern-Nichols…·Dmitry B. Veprintsev
This study shows that agonist efficacy at the {beta}2AR is determined by differences in receptor affinity for Gs protein, not ligand binding kinetics.
5 citations